|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0220908,
umls-concept:C0231221,
umls-concept:C0439611,
umls-concept:C0596545,
umls-concept:C1277187,
umls-concept:C1524063,
umls-concept:C1527178,
umls-concept:C1623258,
umls-concept:C1705938,
umls-concept:C2709270,
umls-concept:C2728259
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-1-5
|
|
pubmed:abstractText |
Patients with asymptomatic left ventricular systolic dysfunction (ALVSD) have an increased risk of heart failure (HF) and a worse life expectancy. Since valuable therapies may prevent such dismal evolution, screening programs for ALVSD have recently been advocated to detect as early as possible such ominous condition. Echocardiography represents the gold standard for the assessment of ALVSD but its indiscriminate use in screening programs is impractical. Clinical multivariate risk assessment associated with ECG and serum brain natriuretic peptide (BNP) may be a feasible strategy to screen ALVSD. We prospectively sought to investigate the feasibility and effectiveness of a screening program for ALVSD based on ECG and BNP used in a hierarchical sequence in patients at high risk for HF.
|
|
pubmed:language |
ita
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1827-6806
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
835-43
|
|
pubmed:meshHeading |
pubmed-meshheading:19119693-Aged,
pubmed-meshheading:19119693-Aged, 80 and over,
pubmed-meshheading:19119693-Cost-Benefit Analysis,
pubmed-meshheading:19119693-Electrocardiography,
pubmed-meshheading:19119693-Feasibility Studies,
pubmed-meshheading:19119693-Female,
pubmed-meshheading:19119693-Heart Failure,
pubmed-meshheading:19119693-Humans,
pubmed-meshheading:19119693-Male,
pubmed-meshheading:19119693-Mass Screening,
pubmed-meshheading:19119693-Middle Aged,
pubmed-meshheading:19119693-Natriuretic Agents,
pubmed-meshheading:19119693-Natriuretic Peptide, Brain,
pubmed-meshheading:19119693-Program Evaluation,
pubmed-meshheading:19119693-Prospective Studies,
pubmed-meshheading:19119693-Risk Assessment,
pubmed-meshheading:19119693-Sensitivity and Specificity,
pubmed-meshheading:19119693-Ventricular Dysfunction, Left
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
|
|
pubmed:affiliation |
Dipartimento di Cardiologia, Ospedale San Martino, Belluno. gitarant@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
